Enovis Corporation will hold an investor call on May 8, 2025, to discuss Q1 financial results.
Quiver AI Summary
Enovis Corporation announced it will hold an investor conference call and live webcast to discuss its first quarter 2025 financial results on May 8, 2025, at 8:30 a.m. Eastern Time, with an earnings press release issued earlier that morning. Interested investors can access the webcast on the Enovis website and participate in the call by dialing a provided number. A replay will be available later that day. Enovis, listed on the NYSE under the ticker ENOV, is focused on developing innovative medical technologies that enhance patient outcomes and streamline workflows, particularly in orthopedics. The company encourages stakeholders to stay informed through its various communications, including SEC filings and press releases.
Potential Positives
- Enovis Corporation is scheduled to host an investor conference call to discuss its first quarter 2025 financial results, demonstrating transparency and engagement with investors.
- The company emphasizes its commitment to innovation and improving patient outcomes, which can enhance its reputation and attract interest from stakeholders in the medical technology sector.
- The availability of a live webcast and replay for the conference call showcases Enovis' dedication to making financial information accessible to a broad audience.
Potential Negatives
- There is no specific financial data or performance metrics provided in the press release, which may lead to uncertainty among investors regarding the company’s current financial health.
- The announcement of an upcoming earnings call could indicate that the company has not met expectations in the past quarter, potentially raising concerns about performance.
- Enovis emphasizes its commitment to innovation and patient outcomes, yet the lack of recent advancements or specific achievements in this area may reflect stagnation or challenges faced by the company.
FAQ
When is the Enovis first quarter 2025 earnings call?
The Enovis first quarter 2025 earnings call is scheduled for Thursday, May 8th, 2025 at 8:30 a.m. Eastern Time.
How can I access the Enovis conference call?
Investors can access the conference call by dialing (833) 335-0887 and using the Access Code: 482081.
Where can I find the earnings press release?
The earnings press release will be issued on the Enovis website earlier on May 8th, 2025.
Is there a way to preregister for the investor call?
Yes, participants may preregister for the call via a provided link on the Enovis website.
Will a replay of the call be available?
A replay of the call will be available on the Enovis website later that same day.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ENOV Hedge Fund Activity
We have seen 166 institutional investors add shares of $ENOV stock to their portfolio, and 129 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 1,307,680 shares (-69.5%) from their portfolio in Q4 2024, for an estimated $57,380,998
- CHANNING CAPITAL MANAGEMENT, LLC removed 1,262,004 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $55,376,735
- AMERICAN CENTURY COMPANIES INC added 825,936 shares (+35.5%) to their portfolio in Q4 2024, for an estimated $36,242,071
- CITADEL ADVISORS LLC added 720,505 shares (+263.2%) to their portfolio in Q4 2024, for an estimated $31,615,759
- HOOD RIVER CAPITAL MANAGEMENT LLC added 661,430 shares (+inf%) to their portfolio in Q4 2024, for an estimated $29,023,548
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 469,498 shares (-7.1%) from their portfolio in Q4 2024, for an estimated $20,601,572
- BNP PARIBAS FINANCIAL MARKETS added 463,815 shares (+inf%) to their portfolio in Q4 2024, for an estimated $20,352,202
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Wilimington, DE, April 17, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2025 financial results on Thursday, May 8th, 2025 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, can be accessed from the "Investors" section of Enovis' website at
www.enovis.com
.
Conference Call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 335-0887 and use the Access Code: 482081. Participants may also preregister at this link . A replay of the call will also be available on the Enovis website later that day.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com .
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
[email protected]
